External Mid-term Evaluation Of The Lebanon National Mental Health Strategy 2015-2020

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
R03AK06	SEROFLO 250	G	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 250mcg/inhalation		Inhalation suspension	1,580,359 L.L
D03BA	SERODASE	G	Serratiopeptidase - 5mg	5mg	Tablet, enteric coated	460,938 L.L
N06CA02	SERNIL	G	Flupentixol - 0.5mg, Melitracen - 10mg		Tablet	1,003,402 L.L
R03AK06	SERETIDE DISKUS 500	B	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 500mcg/inhalation		Inhalation powder	3,199,689 L.L
R03AK06	SERETIDE DISKUS 250	B	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 250mcg/inhalation		Inhalation powder	2,830,132 L.L
R03AK06	SERETIDE DISKUS 100	B	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 100mcg/inhalation		Inhalation powder	2,276,469 L.L
S02AA15	SEPTOCIPRO OTICO	B	Ciprofloxacine (HCl) - 1mg/0.5ml	1mg/0.5ml	Solution	473,033 L.L
N01BB58	SEPTANEST ADRENALINEE	B	Articaine HCl - 72mg/1.8ml, Adrenaline (tartrate) - 0.033mg/1.8ml	1/100,000	Injectable solution	2,945,703 L.L
N03AX09	SEIZET 25	G	Lamotrigine - 25mg	25mg	Tablet, dispersible/ chewable	573,821 L.L
G04BE03	SEGUREX	G	Sildenafil (citrate) - 50mg	50mg	Tablet, film coated	315,803 L.L
J01DD15	SEFARIN	G	Cefdinir - 300mg	300mg	Capsule	1,494,353 L.L
J01DD15	SEFARIN	G	Cefdinir - 125mg/5ml	125mg/5ml	Suspension	939,346 L.L
J01DD15	SEFARIN	G	Cefdinir - 125mg/5ml	125mg/5ml	Suspension	1,695,929 L.L
R03BB06	SEEBRI BREEZHALER	B	Glycopyronium Bromide - 50mcg	50mcg	Capsule, inhalation	2,687,685 L.L
N05BA25	SEDOXIL	G	Mexazolam - 1mg	1mg	Tablet	1,705,336 L.L
C05AA01	SEDIPROCT	G	Hydrocortisone - 5mg, Cinchocaine HCl - 5mg, Framycetin sulfate - 10mg, Esculoside - 10mg		Suppository	237,860 L.L
C05AA01	SEDIPROCT	G	Hydrocortisone - 500mg, Cinchocaine HCl - 500mg		Cream	290,270 L.L
P01AB07	SECNOL	G	Secnidazole - 2g	2g	Granules	842,589 L.L
P01AB07	SECNOL	G	Secnidazole anhydre - 2g	2g	Granules	842,589 L.L
A03BB01	SCOPINAL	G	Butylscopolamine bromide - 20mg/ml	20mg/ml	Injectable solution	178,731 L.L
A03BB01	SCOPINAL	G	Butylscopolamine bromide - 5mg/5ml	5mg/5ml	Syrup	210,983 L.L
A03BB01	SCOPINAL	G	Butylscopolamine bromide - 10mg	10mg	Tablet, film coated	162,605 L.L
A03BB01	SCOBUREN	G	Butylscopolamine bromide - 20mg/ml	20mg/ml	Injectable solution	370,901 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	17,079,643 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	18,264,981 L.L
N01BB03	SCANDINIBSA	G	Mepivacaine HCl - 3%	3%	Injectable solution	1,191,988 L.L
A10BJ02	SAXENDA	BioTech	Liraglutide - 6mg/ml	6mg/ml	Injectable solution	16,747,035 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	L.L

تقييم منتصف المدة خارجي للاستراتجية الوطنية للصحة النفسية ٢٠١٥-٢٠٢٠